日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ChemoID-guided therapy improves objective response rate in recurrent platinum-resistant ovarian cancer randomized clinical trial

ChemoID指导的治疗可提高复发性铂耐药卵巢癌的客观缓解率:随机临床试验

Herzog, Thomas J; Krivak, Thomas C; Bush, Stephen 2nd; Diaz, John P; Lentz, Scott; Nair, Navya; Zgheib, Nadim Bou; Gunderson-Jackson, Camille; Barve, Abhijit; Denning, Krista L; Lirette, Seth T; Howard, Candace M; Valluri, Jagan; Claudio, Pier Paolo

Population pharmacokinetics and exposure-response relationships of dostarlimab in primary advanced or recurrent endometrial cancer in part 1 of RUBY

RUBY研究第一部分:多斯利单抗在原发性、晚期或复发性子宫内膜癌中的群体药代动力学和暴露-反应关系

Kuchimanchi, Mita; Jørgensen, Trine Lembrecht; Hanze, Eva; André, Thierry; Jain, Angela; Berton, Dominique; Alskär, Oskar; Zub, Oleksandr; Oaknin, Ana; Shahin, Mark S; Koliadi, Anthoula; Pothuri, Bhavana; Krivak, Tom; Pishchyk, Mikalai; Segev, Yakir; Backes, Floor J; Gennigens, Christine; Bouberhan, Sara; Zajic, Stefan; Melhem, Murad; Buscema, Joseph

PARP Inhibitors in Ovarian Cancer: A Review

PARP抑制剂在卵巢癌中的应用:综述

O'Malley, David M; Krivak, Thomas C; Kabil, Nashwa; Munley, Jiefen; Moore, Kathleen N

PrankWeb 3: accelerated ligand-binding site predictions for experimental and modelled protein structures

PrankWeb 3:加速预测实验和模型蛋白质结构的配体结合位点

Jakubec, David; Skoda, Petr; Krivak, Radoslav; Novotny, Marian; Hoksza, David

Livestock impacts on an iconic Namib Desert plant are mediated by abiotic conditions

牲畜对纳米布沙漠标志性植物的影响受非生物因素调节。

Kerby, Jeffrey T; Krivak-Tetley, Flora E; Shikesho, Saima D; Bolger, Douglas T

Fertility-sparing treatment of locally advanced vulvar squamous cell carcinoma in a young patient

年轻患者局部晚期外阴鳞状细胞癌的保留生育功能的治疗

Vue, Nujsaubnusi C; Gaulin, Nicole B; Horne, Zachary D; Liang, Sharon; Krivak, Thomas C

Differential gene expression identifies a transcriptional regulatory network involving ER-alpha and PITX1 in invasive epithelial ovarian cancer

差异基因表达确定了侵袭性上皮性卵巢癌中涉及 ER-alpha 和 PITX1 的转录调控网络

Yichao Li, Sushil K Jaiswal, Rupleen Kaur, Dana Alsaadi, Xiaoyu Liang, Frank Drews, Julie A DeLoia, Thomas Krivak, Hanna M Petrykowska, Valer Gotea, Lonnie Welch, Laura Elnitski

Invasive endometrial adenocarcinoma and missed abortion: A case report

浸润性子宫内膜腺癌和稽留流产:病例报告

Gaulin, Nicole B; Harinath, Lakshmi; Liang, Sharon; Krivak, Thomas C; Miller, Eirwen M

Corrigendum to "Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study" [Gynecol. Oncol. 151 (2018) 18-23]

对“辅助化疗剂量调整是否会影响晚期卵巢癌患者的预后?NRG肿瘤学/妇科肿瘤学组研究”的更正[妇科肿瘤学 151 (2018) 18-23]

Olawaiye, Alexander B; Java, James J; Krivak, Thomas C; Friedlander, Michael; Mutch, David G; Glaser, Gretchen; Geller, Melissa; O'Malley, David M; Wenham, Robert M; Lee, Roger B; Bodurka, Diane C; Herzog, Thomas J; Bookman, Michael A

Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study

辅助化疗剂量调整是否会影响晚期卵巢癌患者的预后?一项NRG肿瘤/妇科肿瘤组研究

Olawaiye, Alexander B; Java, James J; Krivak, Thomas C; Friedlander, Michael; Mutch, David G; Glaser, Gretchen; Geller, Melissa; O'Malley, David M; Wenham, Robert M; Lee, Roger B; Bodurka, Diane C; Herzog, Thomas J; Bookman, Michael A